Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses
about
Structural characterization of viral epitopes recognized by broadly cross-reactive antibodiesHeterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityInfluenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 VirusesA recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutininDefining the antibody cross-reactome directed against the influenza virus surface glycoproteins.Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesNeutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.Recombinant influenza A H3N2 viruses with mutations of HA transmembrane cysteines exhibited altered virological characteristics.Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.Porcine mast cells infected with H1N1 influenza virus release histamine and inflammatory cytokines and chemokines.Current status and prospects for development of an HSV vaccineA carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates.Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire.Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virusChimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodiesHost versus flu: antibodies win a round?Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.Broadly neutralizing antibodies against influenza viruses.Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.Strategies to induce broadly protective antibody responses to viral glycoproteins.A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity.Prospects of HA-based universal influenza vaccine.Timescales of influenza A/H3N2 antibody dynamicsIsolation and Characterization of Human Monoclonal Antibodies That Recognize the Influenza A(H1N1)pdm09 Virus Hemagglutinin Receptor-Binding Site and Rarely Yield Escape Mutant Viruses
P2860
Q26823492-0D92A6C9-E0C1-4EB8-B43E-8264E8FBFBDDQ27673861-CFDF79D6-40AF-4B69-B14B-E58D792C7691Q27675477-10F20CB4-054C-4027-85A3-272E65EE1B4CQ27676298-EC45BA92-E4E9-4C2A-8513-42D47A5EB33CQ30151352-360C2FAE-A50D-41A2-92F4-92287B945898Q30209342-0C7B46E9-F4A5-4580-AFDE-BA0603FE182FQ30352862-81A0D109-4E76-40E7-90C2-47EFA1B011AEQ30355996-2CCC2AA3-BBA1-4705-8815-9249DBC17F5FQ30377531-2F50F022-5A18-444E-AC6D-4D5CD77BE1BAQ30396997-EAB4194F-7280-4F12-ABE7-49D64890675CQ33931016-D41A9E64-A187-4C16-8CA6-B07FF908BB81Q34395834-1053B7B1-E775-411A-B819-8536DA8C8AB6Q35850197-2D80AE13-373A-40F5-BA92-84F4569242D6Q36147360-8CB7E9E1-0201-4B4B-B6CA-9C58B1455E03Q36708487-B9709B39-F4E8-457A-89C8-4EC9209E4E58Q36911722-2F9CE491-4987-4111-A39F-98CC7595960EQ37146938-C3ABDB27-CDC6-41A0-9D6C-2890C8C191F4Q37184801-F810BFB2-1044-4EF4-9959-145FC057C240Q37252968-29B899CB-3AEF-4DB6-AB6B-8325626EF0F2Q37704975-AFB3D4C0-C215-46EF-8063-7B575FFC94B3Q38050485-DE4D5173-BEAD-4C26-98A6-EC13870B8F2FQ39170802-C1990BE0-2569-470E-8783-9057A42DB1BBQ39397313-A7AF7298-0024-41ED-8BC2-3873C7C66816Q40043685-9A17680A-44E4-467D-8B69-E92F813372CCQ40201534-BB72BF52-7B3C-48D6-A444-5AB49097BD32Q41416400-3E6C6D7A-7BEF-480F-98D0-A246B20CAE78Q58734451-60EAD120-A758-41A5-A11C-CDEDCD9F7B45Q59132925-01659956-BF16-4B5C-8361-F572ACD01325
P2860
Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Human monoclonal antibodies to ...... ic 1968 H3N2 influenza viruses
@ast
Human monoclonal antibodies to ...... ic 1968 H3N2 influenza viruses
@en
type
label
Human monoclonal antibodies to ...... ic 1968 H3N2 influenza viruses
@ast
Human monoclonal antibodies to ...... ic 1968 H3N2 influenza viruses
@en
prefLabel
Human monoclonal antibodies to ...... ic 1968 H3N2 influenza viruses
@ast
Human monoclonal antibodies to ...... ic 1968 H3N2 influenza viruses
@en
P2093
P2860
P50
P356
P1433
P1476
Human monoclonal antibodies to ...... ic 1968 H3N2 influenza viruses
@en
P2093
Chelsey J Huffman
David L Blum
Jens C Krause
Tshidi Tsibane
P2860
P304
P356
10.1128/JVI.07158-11
P50
P577
2012-03-28T00:00:00Z